|
ZNF439 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.049500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.329150E-01 |
| Normal-vs-Stage2 |
6.112000E-01 |
| Normal-vs-Stage3 |
1.044010E-03 |
| Normal-vs-Stage4 |
1.501100E-03 |
| Stage1-vs-Stage2 |
8.612400E-01 |
| Stage1-vs-Stage3 |
5.108100E-02 |
| Stage1-vs-Stage4 |
1.249030E-01 |
| Stage2-vs-Stage3 |
1.804810E-01 |
| Stage2-vs-Stage4 |
1.349590E-01 |
| Stage3-vs-Stage4 |
7.354000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.823800E-02 |
| Normal-vs-AfricanAmerican |
5.661600E-01 |
| Normal-vs-Asian |
5.806800E-01 |
| Caucasian-vs-AfricanAmerican |
3.486200E-01 |
| Caucasian-vs-Asian |
8.955400E-01 |
| AfricanAmerican-vs-Asian |
6.358000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.791500E-02 |
| Normal-vs-Female |
8.639800E-01 |
| Male-vs-Female |
8.782300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.743820E-01 |
| Normal-vs-Extreme_Weight |
5.480100E-02 |
| Normal-vs-Obese |
3.811800E-01 |
| Normal-vs-Extreme_Obese |
3.513700E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.546400E-01 |
| Normal_Weight-vs-Obese |
6.136400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.349800E-01 |
| Extreme_Weight-vs-Obese |
3.676000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.791200E-01 |
| Obese-vs-Extreme_Obese |
2.876200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.374400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.918800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.607800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.075160E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.304200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.230400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.213600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.393000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.059800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.267630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.958800E-01 |
| Normal-VS-Type2 PRCC |
1.20960000016268E-07 |
| Normal-VS-KIRP CIMP |
3.318100E-02 |
| Normal-VS-Unclassified PRCC |
3.037400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.20080001497769E-09 |
| Type1 PRCC-VS-KIRP CIMP |
1.613380E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.362200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.733400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.637790E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
2.663000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.081500E-03 |
| Normal-vs-N1 |
1.484390E-03 |
| Normal-vs-N2 |
7.750000E-04 |
| N0-vs-N1 |
5.351000E-01 |
| N0-vs-N2 |
1.430420E-01 |
| N1-vs-N2 |
2.638400E-01 |
|
|
